Answers are grounded in this paper and cite their sources.
This review highlights recent progress in electrochemical biosensors, emphasizing nanomaterials and biomarkers in epithelial cancer diagnosis.
In recent years, the interest in electrochemical biosensors has been constantly growing for epithelial cancer diagnosis and prognosis. The incorporation of the different nanomaterials, specific monoclonal antibodies, and nucleic acids (aptamers) into these methodologies has managed to improve sensitivity and specificity. In this review, we have presented examples of electrochemical biosensors for the determination of different epithelial cancer biomarkers. Based on many published literature examples, we have emphasized the recent application of one and multiplexed platforms for the quantification of epithelial cancer biomarkers. Finally, we discussed the possible way of development, challenges, and future perspectives in the area of electrochemical immuno-, apta-, and geno-sensors.
No takes yet. Share an insight, caveat, or question.
Regiart et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: